These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 36840825)

  • 1. Impact of renal replacement therapy strategy on beta-lactam plasma concentrations: the BETAKIKI study-an ancillary study of a randomized controlled trial.
    Roux D; Benichou N; Hajage D; Martin-Lefèvre L; de Prost N; Lerolle N; Titeca-Beauport D; Boulet E; Mayaux J; Mégarbane B; Mahjoub K; Carpentier D; Nseir S; Tubach F; Ricard JD; Dreyfuss D; Gaudry S;
    Ann Intensive Care; 2023 Feb; 13(1):11. PubMed ID: 36840825
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of Early vs Delayed Initiation of Renal Replacement Therapy on Mortality in Critically Ill Patients With Acute Kidney Injury: The ELAIN Randomized Clinical Trial.
    Zarbock A; Kellum JA; Schmidt C; Van Aken H; Wempe C; Pavenstädt H; Boanta A; Gerß J; Meersch M
    JAMA; 2016 May 24-31; 315(20):2190-9. PubMed ID: 27209269
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Timing of Renal Support and Outcome of Septic Shock and Acute Respiratory Distress Syndrome. A Post Hoc Analysis of the AKIKI Randomized Clinical Trial.
    Gaudry S; Hajage D; Schortgen F; Martin-Lefevre L; Verney C; Pons B; Boulet E; Boyer A; Chevrel G; Lerolle N; Carpentier D; de Prost N; Lautrette A; Bretagnol A; Mayaux J; Nseir S; Megarbane B; Thirion M; Forel JM; Maizel J; Yonis H; Markowicz P; Thiery G; Tubach F; Ricard JD; Dreyfuss D
    Am J Respir Crit Care Med; 2018 Jul; 198(1):58-66. PubMed ID: 29351007
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Artificial Kidney Initiation in Kidney Injury 2 (AKIKI2): study protocol for a randomized controlled trial.
    Gaudry S; Hajage D; Martin-Lefevre L; Louis G; Moschietto S; Titeca-Beauport D; La Combe B; Pons B; de Prost N; Besset S; Combes A; Robine A; Beuzelin M; Badie J; Chevrel G; Reignier J; Bohé J; Coupez E; Chudeau N; Barbar S; Vinsonneau C; Forel JM; Thevenin D; Boulet E; Lakhal K; Aissaoui N; Grange S; Leone M; Lacave G; Nseir S; Poirson F; Mayaux J; Asehnoune K; Geri G; Klouche K; Thiery G; Argaud L; Ricard JD; Quenot JP; Dreyfuss D
    Trials; 2019 Dec; 20(1):726. PubMed ID: 31843007
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Continuous renal replacement therapy versus intermittent hemodialysis as first modality for renal replacement therapy in severe acute kidney injury: a secondary analysis of AKIKI and IDEAL-ICU studies.
    Gaudry S; Grolleau F; Barbar S; Martin-Lefevre L; Pons B; Boulet É; Boyer A; Chevrel G; Montini F; Bohe J; Badie J; Rigaud JP; Vinsonneau C; Porcher R; Quenot JP; Dreyfuss D
    Crit Care; 2022 Apr; 26(1):93. PubMed ID: 35379300
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predictive factors for severe long-term chronic kidney disease after acute kidney injury requiring renal replacement therapy in critically ill patients: an ancillary study of the ELVIS randomized controlled trial.
    Soum E; Timsit JF; Ruckly S; Gruson D; Canet E; Klouche K; Argaud L; Garrouste-Orgeas M; Mariat C; Vincent F; Cayot S; Darmon M; Bohé J; Schwebel C; Bouadma L; Dupuis C; Souweine B; Lautrette A
    Crit Care; 2022 Nov; 26(1):367. PubMed ID: 36447221
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Timing of renal replacement therapy initiation for acute kidney injury in critically ill patients: a systematic review of randomized clinical trials with meta-analysis and trial sequential analysis.
    Li X; Liu C; Mao Z; Li Q; Zhou F
    Crit Care; 2021 Jan; 25(1):15. PubMed ID: 33407756
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of two strategies for initiating renal replacement therapy in the intensive care unit: study protocol for a randomized controlled trial (AKIKI).
    Gaudry S; Hajage D; Schortgen F; Martin-Lefevre L; Tubach F; Pons B; Boulet E; Boyer A; Lerolle N; Chevrel G; Carpentier D; Lautrette A; Bretagnol A; Mayaux J; Thirion M; Markowicz P; Thomas G; Dellamonica J; Richecoeur J; Darmon M; de Prost N; Yonis H; Megarbane B; Loubières Y; Blayau C; Maizel J; Zuber B; Nseir S; Bigé N; Hoffmann I; Ricard JD; Dreyfuss D
    Trials; 2015 Apr; 16():170. PubMed ID: 25902813
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Clinical characteristics and prognosis of acute kidney injury in elderly patients with sepsis].
    Wang J; Li J; Wang Y
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2019 Jul; 31(7):837-841. PubMed ID: 31441406
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Delayed versus early initiation of renal replacement therapy for severe acute kidney injury: a systematic review and individual patient data meta-analysis of randomised clinical trials.
    Gaudry S; Hajage D; Benichou N; Chaïbi K; Barbar S; Zarbock A; Lumlertgul N; Wald R; Bagshaw SM; Srisawat N; Combes A; Geri G; Jamale T; Dechartres A; Quenot JP; Dreyfuss D
    Lancet; 2020 May; 395(10235):1506-1515. PubMed ID: 32334654
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of two delayed strategies for renal replacement therapy initiation for severe acute kidney injury (AKIKI 2): a multicentre, open-label, randomised, controlled trial.
    Gaudry S; Hajage D; Martin-Lefevre L; Lebbah S; Louis G; Moschietto S; Titeca-Beauport D; Combe B; Pons B; de Prost N; Besset S; Combes A; Robine A; Beuzelin M; Badie J; Chevrel G; Bohé J; Coupez E; Chudeau N; Barbar S; Vinsonneau C; Forel JM; Thevenin D; Boulet E; Lakhal K; Aissaoui N; Grange S; Leone M; Lacave G; Nseir S; Poirson F; Mayaux J; Asehnoune K; Geri G; Klouche K; Thiery G; Argaud L; Rozec B; Cadoz C; Andreu P; Reignier J; Ricard JD; Quenot JP; Dreyfuss D
    Lancet; 2021 Apr; 397(10281):1293-1300. PubMed ID: 33812488
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Analysis of the characteristics of patients suffering from acute kidney injury following severe trauma receiving renal replacement therapy].
    Zhu J; Zhang M
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2015 May; 27(5):349-53. PubMed ID: 26003638
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Subtherapeutic initial β-lactam concentrations in select critically ill patients: association between augmented renal clearance and low trough drug concentrations.
    Udy AA; Varghese JM; Altukroni M; Briscoe S; McWhinney BC; Ungerer JP; Lipman J; Roberts JA
    Chest; 2012 Jul; 142(1):30-39. PubMed ID: 22194591
    [TBL] [Abstract][Full Text] [Related]  

  • 14. STandard versus Accelerated initiation of Renal Replacement Therapy in Acute Kidney Injury: Study Protocol for a Multi-National, Multi-Center, Randomized Controlled Trial.
    STARRT-AKI Investigators
    Can J Kidney Health Dis; 2019; 6():2054358119852937. PubMed ID: 31218013
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Insufficient β-lactam concentrations in the early phase of severe sepsis and septic shock.
    Taccone FS; Laterre PF; Dugernier T; Spapen H; Delattre I; Wittebole X; De Backer D; Layeux B; Wallemacq P; Vincent JL; Jacobs F
    Crit Care; 2010; 14(4):R126. PubMed ID: 20594297
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The timing of continuous renal replacement therapy initiation in sepsis-associated acute kidney injury in the intensive care unit: the CRTSAKI Study (Continuous RRT Timing in Sepsis-associated AKI in ICU): study protocol for a multicentre, randomised controlled trial.
    Chen WY; Cai LH; Zhang ZH; Tao LL; Wen YC; Li ZB; Li L; Ling Y; Li JW; Xing R; Liu XY; Lin ZD; Deng ZT; Wang SH; Lin QH; Zhou DR; He ZJ; Xiong XM
    BMJ Open; 2021 Feb; 11(2):e040718. PubMed ID: 33608398
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact on mortality of the timing of renal replacement therapy in patients with severe acute kidney injury in septic shock: the IDEAL-ICU study (initiation of dialysis early versus delayed in the intensive care unit): study protocol for a randomized controlled trial.
    Barbar SD; Binquet C; Monchi M; Bruyère R; Quenot JP
    Trials; 2014 Jul; 15():270. PubMed ID: 24998258
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Effect of Renal Replacement Therapy and Antibiotic Dose on Antibiotic Concentrations in Critically Ill Patients: Data From the Multinational Sampling Antibiotics in Renal Replacement Therapy Study.
    Roberts JA; Joynt GM; Lee A; Choi G; Bellomo R; Kanji S; Mudaliar MY; Peake SL; Stephens D; Taccone FS; Ulldemolins M; Valkonen MM; Agbeve J; Baptista JP; Bekos V; Boidin C; Brinkmann A; Buizen L; Castro P; Cole CL; Creteur J; De Waele JJ; Deans R; Eastwood GM; Escobar L; Gomersall C; Gresham R; Jamal JA; Kluge S; König C; Koulouras VP; Lassig-Smith M; Laterre PF; Lei K; Leung P; Lefrant JY; Llauradó-Serra M; Martin-Loeches I; Mat Nor MB; Ostermann M; Parker SL; Rello J; Roberts DM; Roberts MS; Richards B; Rodríguez A; Roehr AC; Roger C; Seoane L; Sinnollareddy M; Sousa E; Soy D; Spring A; Starr T; Thomas J; Turnidge J; Wallis SC; Williams T; Wittebole X; Zikou XT; Paul SK; Lipman J;
    Clin Infect Dis; 2021 Apr; 72(8):1369-1378. PubMed ID: 32150603
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fluid balance and renal replacement therapy initiation strategy: a secondary analysis of the STARRT-AKI trial.
    Wald R; Kirkham B; daCosta BR; Ghamarian E; Adhikari NKJ; Beaubien-Souligny W; Bellomo R; Gallagher MP; Goldstein S; Hoste EAJ; Liu KD; Neyra JA; Ostermann M; Palevsky PM; Schneider A; Vaara ST; Bagshaw SM
    Crit Care; 2022 Nov; 26(1):360. PubMed ID: 36424662
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.